Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management (Q79765035)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

editorial

0 references

title

Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1 reference

Halimi S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

555-556

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Efficacy of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Role of metformin accumulation in metformin-associated lactic acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970309-9

7 January 2021

10.1016/S1262-3636(07)70309-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296508%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference